Pharmacological Targeting of Arylamine N-Acetyltransferase I

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/569695

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project will investigate a novel approach to controlling how cancer cells grow and spread. It plans to study whether a protein termed N-acetyltransferase is a key to determining whether cancer cells can change thier characteristics, allowing them to invade other tissues. In addition, novel approaches to target this protein are proposed. If successful, the work outlined in this project will open new avenues to understanding and trerating cancers.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $474,653.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical biochemistry - carbohydrates

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cancer | Drug development | Drug targeting | E-cadherin | Gene regulation | Growth | Pharmacology

Related Links